Open Access
Access granted
Subscription or Fee Access
Vol 24, No 12 (2013)
- Year: 2013
- Articles: 21
- URL: https://journals.eco-vector.com/0236-3054/issue/view/5930
Articles
β 2-ADRENOCEPTOR GENE POLYMORPHISM AND THE COURSE OF ASTHMA
Abstract
Asthmatic patients without the 16ArgArg+ genotype were recorded to develop exacerbations more frequently if they do not receive adequate anti-inflammatory therapy. The use of inhaled glucocorticosteroids, as well as long-acting β-adrenomimetics for planned therapy in the patients can substantially reduce the number of exacerbations.
Vrach. 2013;24(12):2-5
2-5
GASTROINTESTINAL COMPLICATIONS OF DIABETES MELLITUS
Abstract
Vascular complications, nephropathy, and neuropathies at different sites are the main cause of death in patients with any type of diabetes mellitus (DM) and closely related to poor hyperglycemia control during treatment. In the presence of insulin resistance and type 2 DM, gastrointestinal complications occur more frequently; furthermore, most patients develop fatty liver disease. The latter, an independent predictor for the progression of DM and its complications, requires detection and treatment in the early stage of the disease.
Vrach. 2013;24(12):6-18
6-18
RESPIRATORY COMPLICATIONS OF OBESITY
Abstract
In parallel with the prevalence of obesity, the number of its complications, including breathing problems, is on the increase. The paper discusses recognized obesity concomitants, such as obstructive sleep apnea syndrome and obesity hypoventilation syndrome.
Vrach. 2013;24(12):18-20
18-20
USE OF CORAXAN IN PATIENTS WITH ACUTE CORONARY SYNDROME
Abstract
Addition of Coraxan in a daily dose of 10-15 mg to standard antianginal therapy in acute coronary syndrome patients prone to hypotension and, in this connection, the complexity of titration of β-adrenoblockers promoted an increase in exercise endurance, a reduction in the number of angina attacks, achievement of normocardia, without additionally lowering blood pressure, as well as a decrease in the frequency of ventricular and supraventricular arrhythmias. The test drug was noted to be well tolerated.
Vrach. 2013;24(12):21-24
21-24
25-27
CORRECTION OF CEREBROVASCULAR DISORDERS IN PATIENTS WITH IDIOPATHIC ARTERIAL HYPOTENSION
Abstract
Chronic cerebrovascular disease that had developed in the presence of idiopathic arterial hypotension was studied in young people. Its leading clinical syndromes were revealed; the prevalence and severity of cognitive impairments and psychoemotional disorders were determined. Noopept demonstrated its high efficacy in treating chronic cerebrovascular disease.
Vrach. 2013;24(12):27-31
27-31
THE VASCULAR BED IN PREMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN ESTROGEN DEFICIENCY
Abstract
The premenopausal women with arterial hypertension (AH) and dyslipidemia in hypoestrogenemia were found to have significant structural and functional alterations in the vessel wall as atherosclerosis. Better results were obtained in the group receiving combination therapy with Mertenil (rosuvastatin) and Diroton (lisinopril).
Vrach. 2013;24(12):31-36
31-36
37-39
THE DRUG PREDUCTAL IN TREATMENT AND PREVENTIVE MEASURES FOR PATIENTS WITH ISCHEMIC HEART DISEASE
Abstract
We present the analysis of experimental and clinical researches of the drug Preductal administration. We have showed the effectiveness of this medicine for preventive measures for cardiovascular complications with patients with different forms of ischemic heart disease.
Vrach. 2013;24(12):40-41
40-41
42-46
ROLE OF COPPER AND MANGANESE IN IRON METABOLISM
Abstract
Twenty-two manganese proteins and 9 cuproenzymes are involved in human iron metabolism. Iron monotherapy fails to take into account trace element interactions and may be therefore accompanied by the higher rates of side effects, and, in case of copper deficiency, may cause the body’s iron overload or treatment refractoriness. The use of a combination of iron, copper, and manganese allows such results to be avoided.
Vrach. 2013;24(12):47-52
47-52
TREATMENT FOR ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH CARDIOVASCULAR DISEASES
Abstract
Anxiety and depressive disorders (ADD) are regarded as an independent risk factor for the development and progression of cardiovascular diseases. Incorporation of the Russian anxiolytic Afobazole in treatment regimens for the above diseases is not only accompanied by a reduction in ADD, but also enhances the efficiency of antihypertensive, antianginal, and antiarrhythmic therapies.
Vrach. 2013;24(12):53-58
53-58
59-63
63-66
66-69
HEPATIC FUNCTIONAL IMPAIRMENT IN THE FIRST HALF OF PREGNANCY
Abstract
The paper discusses the possible mechanisms of liver damage as a consequence of the failing compensatory capacities of metabolic enzymatic systems in pregnant women exposed to high concentrations of endo- and exogenous sex hormones. It proposes measures to prevent this condition. Ursodeoxycholic acid preparations are shown to be highly effective and safe in normalizing laboratory markers for liver damage in the first half of pregnancy.
Vrach. 2013;24(12):70-73
70-73
74-77
CLINICAL FEATURES OF CONGENITAL RENAL HYPOPLASIA IN CHILDREN IN RELATION TO AGE AND THE SIDE OF LESION
Abstract
The paper gives the clinical features of congenital renal hypoplasia in children in relation to the age of its diagnosis. It presents laboratory and instrumental findings of these patients. The degree of kidney dysfunction is shown to vary greatly in them.
Vrach. 2013;24(12):78-80
78-80
81-82
83-85
ON THE PATHOGENESIS OF NEUROLEPTIC CARDIOMYOPATHY
Abstract
Using the results of analyzing the literature and some his findings, the author considers one of the aspects of the pathogenesis of neuroleptic cardiomyopathy that is a little studied iatrogenic disease caused by the adverse cardiotoxic effect of antipsychotic drugs. The cardiotoxic effects of neuroleptics include myocardial ischemia that underlies myocardial dysfunction and ventricular remodeling. The mechanism for the development of myocardial ischemia at an organ level is associated with hypotension and persistent tachycardia, which are constant concomitants of neuroleptic therapy.
Vrach. 2013;24(12):86-87
86-87